Newbridge Financial Services Group’s Tectonic Therapeutic TECX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-31
Closed 1496
2022
Q2
$0 Hold
31
﹤0.01% 1549
2022
Q1
$0 Hold
31
﹤0.01% 1592
2021
Q4
$1K Hold
31
﹤0.01% 1376
2021
Q3
$2K Hold
31
﹤0.01% 1206
2021
Q2
$3K Hold
31
﹤0.01% 1241
2021
Q1
$5K Buy
31
+23
+288% +$3.74K ﹤0.01% 1047
2020
Q4
$1K Hold
8
﹤0.01% 1083
2020
Q3
$1K Buy
+8
New +$1.61K ﹤0.01% 1019

Other funds holding TECX

Newbridge Financial Services Group's TECX Position: Q3 2022 in Review

Newbridge Financial Services Group sold out of Tectonic Therapeutic (TECX) in Q3 2022, closing a stake of 31 shares.

Newbridge Financial Services Group first reported a position in TECX in Q3 2020 and held it in 8 quarters. The position peaked at $5K in Q1 2021. 54 funds tracked by Wall St. Rank hold TECX as of Q3 2022.

  • Newbridge Financial Services Group reported no remaining Tectonic Therapeutic position as of Q3 2022 after selling out during the quarter.
  • Newbridge Financial Services Group sold 31 Tectonic Therapeutic shares in Q3 2022.
  • Newbridge Financial Services Group first reported a position in Tectonic Therapeutic in Q3 2020 and held it in 8 quarters.
  • Newbridge Financial Services Group's Tectonic Therapeutic position peaked at $5K in Q1 2021.
  • 54 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q3 2022.

Based on Newbridge Financial Services Group's 13F filing for Q3 2022, filed 13 Oct 2022.